Click to copy
Click to copy

Allogene Therapeutics: 2Q Earnings Snapshot

August 7, 2019

SOUTH SAN FRANCISCO, Calif. (AP) _ Allogene Therapeutics Inc. (ALLO) on Wednesday reported a loss of $41.2 million in its second quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 41 cents.

The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.

Allogene Therapeutics shares have climbed 10% since the beginning of the year.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO

All contents © copyright 2019 The Associated Press. All rights reserved.